Literature DB >> 1517140

Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989).

C E Atkins1, A M Gallo, I D Kurzman, P Cowen.   

Abstract

Population characteristics, risk factors, and survival characteristics were evaluated in 74 cats with hypertrophic cardiomyopathy (HC) seen at North Carolina State University veterinary teaching hospital from 1985 to 1989, and compared with 82 clinically normal cats. The mean (+/- SD) age of cats with HC was 6.5 (4.0) years. Neutered males were at significantly greater risk (odds ratio 3.1) than neutered females. Breed, body weight, or coat color were not determined to be risk factors for HC. Tricolor cats were significantly underrepresented, probably reflecting the male predisposition for HC and not a true risk reduction associated with coat color. Forty-one cats were without clinical signs of heart disease (murmur and/or gallop sound only), 24 were in congestive heart failure, and 9 had systemic arterial embolism, 3 of which had concomitant congestive heart failure. The median survival time for 61 cats with HC, for which survival information could be obtained and that were not euthanatized on day 1, was 732 days. Survival was not affected by age at diagnosis, breed, body weight, or sex. However, clinical signs were important in determining prognosis; cats with heart rates greater than 200 beats/min survived significantly longer (median survival greater than 1,830 days) than those with heart rates greater than or equal to 200 beats/min (median survival = 152 days). Cats without clinical signs (median survival greater than 1,830 days) survived longer than those with clinical signs, and cats in heart failure survived a median of 92 days, compared with 61 days for those with systemic arterial embolism. Analysis of survival revealed no significant difference between the 2 groups of cats with clinical signs; however, all cats with embolism and only 60% of cats with heart failure were dead 6 months after diagnosis.

Entities:  

Mesh:

Year:  1992        PMID: 1517140

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  27 in total

1.  End-stage hypertrophic cardiomyopathy in a cat.

Authors:  Andrew J M White
Journal:  Can Vet J       Date:  2015-05       Impact factor: 1.008

2.  Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study.

Authors:  Mylène Taillefer; Rocky Di Fruscia
Journal:  Can Vet J       Date:  2006-05       Impact factor: 1.008

3.  Pharmacodynamic effects of ivabradine, a negative chronotropic agent, in healthy cats.

Authors:  Richard E Cober; Karsten E Schober; Tony C A Buffington; Xiaobai Li; Sabine C Riesen; John D Bonagura
Journal:  J Vet Cardiol       Date:  2011-10-24       Impact factor: 1.701

4.  Acute Occlusion of the Abdominal Aorta with Sudden Paraplegia in a Captive Mustached Tamarin (Saguinus mystax).

Authors:  Carmen R Michaud; Richard Herbert; William R Elkins; Alfonso S Gozalo
Journal:  Comp Med       Date:  2017-10-01       Impact factor: 0.982

Review 5.  Nutrition and cardiomyopathy: lessons from spontaneous animal models.

Authors:  Lisa M Freeman; John E Rush
Journal:  Curr Heart Fail Rep       Date:  2007-06

6.  Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease.

Authors:  Sara T Lo; Ashley L Walker; Catherine J Georges; Ronald Hl Li; Joshua A Stern
Journal:  J Feline Med Surg       Date:  2021-05-10       Impact factor: 2.015

7.  Relationship of body size to metabolic markers and left ventricular hypertrophy in cats.

Authors:  L M Freeman; J E Rush; A Feugier; I van Hoek
Journal:  J Vet Intern Med       Date:  2014-11-20       Impact factor: 3.333

8.  Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.

Authors:  K Borgeat; K Sherwood; J R Payne; V Luis Fuentes; D J Connolly
Journal:  J Vet Intern Med       Date:  2014-10-15       Impact factor: 3.333

9.  A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy.

Authors:  Yu Ueda; Ronald H L Li; Nghi Nguyen; Eric S Ontiveros; Samantha L Kovacs; Maureen S Oldach; Karen M Vernau; Michael H Court; Joshua A Stern
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

10.  Prevalence of myocardial hypertrophy in a population of asymptomatic Swedish Maine coon cats.

Authors:  Suzanne Gundler; Anna Tidholm; Jens Häggström
Journal:  Acta Vet Scand       Date:  2008-06-18       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.